Not Yet RecruitingNot Applicable

Validation of a 3D Instrumented Serious Game to Evaluate Upper Limb Impairments in Children With Neuromotor Disorders

Switzerland40 participantsStarted 2025-02

Plain-language summary

The goal of this clinical trial is to validate an instrumented 3D serious game to assess upper limb impairments in children with neuromotor disorders. The main questions are: * Does an instrumented 3D serious game can provide a set of validated upper limb movement features with good reliability, validity and responsiveness ? * Does the instrumented 3D serious game could provide better immersion, adhesion, usability and satisfaction than a "classic" 3D protocol, thanks to the developped environment ? Researchers will compare children with neuromotor disorders and typically developing children to assess discriminant validity of the new assessement. Children with neuromotor disorders will have 2 visits to the hospital : * Visit 1 : children will perform a validated 3D protocol and the instrumented 3D serious game * Visit 2 : children will have a clinical examination and will perform the instrumented 3D serious game Typically developing children will have one visit to the hospital. They will perform the instrumented 3D serious game.

Who can participate

Age range5 Years – 13 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Children with NMD * Informed Consent signed by the subject * Aged from 5 to 13 years, * Non-progressive neurological lesions (cerebral palsy, stroke, traumatic brain injury, etc.), * With sufficient grasp ability to perform the 3D protocol tasks (MACS level I to III), * TD children * Informed Consent signed by the subject * Aged from 5 to 13 years, Exclusion Criteria: * Children with neuromotor disorders * inability to follow the procedures of the investigation because of severe cognitive or visual disturbances, * upper limb (UL) disorders that may affect movement (fractures less than 6 months prior to participation, pain (visual analogic score (VAS) score \> 0), etc.). * previous UL surgery, and botulinum toxin injections less than three months prior to participation, * TD children * Inability to follow the procedures of the investigation because of severe visual disturbances, * UL disorders that may affect movement (fractures less than 6 months prior to participation, pain (VAS score \> 0), etc.).

What they're measuring

Arm Profile Score

Timeframe: Baseline and 2 weeks after

Trial details

NCT IDNCT06774456

SponsorUniversity Hospital, Geneva

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-09

Contact for this trial

Marine Cacioppo, MD, PhD

+41 79 553 84 67 marine.cacioppo@hug.ch